us-abim MCQ (SBA): Diabetic Kidney Disease (SGLT2)

Instant feedback + full explanation. One question, done properly.

ModerateNephrologyDiabetic Kidney Disease (SGLT2)us-abim

A 61-year-old with CKD G2 A2 and T2D is on maximally tolerated ACEi. eGFR 65. UACR 120 mg/g. Which additional therapy slows CKD progression and provides CV benefit?

Practice more on iatroX

Educational content. Not a substitute for clinical judgement or local policy.